GSK2321138A
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GSK2321138A, covering 2013-06-17 to 2017-03-08. Get the full timeline:
Most recent: Clinical Trial Update: An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children [Phase 3]